References: |
Kazuhiko Mishima, Yukimari Kato, Mika Kato Kaneko, Ryo Nishikawa, Takanori Hirose and Masao Matsutani. Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression. Acta Neuropathol March (2006). (paper)
Mohammad Saleem, Vaqar Mustafa Adhmai, Weixiong Zhong, B. Jack Longley, Chen-Yong Lin, Robert B. Dickson, Shannon Reagan-Shaw, David F. Jarrard, and Hasan Mukhtar. A novel biomarker for staging human prostate adenocarcinoma: Overexpression of matriptase with concomitant loss of its inhibitor, hepatocyte growth factor activiator inhibitor-1. Cancer Epidemiol Bioimarker Prev 15(2) 217-227, February (2006). (paper)
Chen-Feng Qi, Shao Xiang, Min Sun Shin, Xingpei Hao, Chang Hoon Lee, Jeff X. Zhou, Ted A. Torrey, Janet W. Hartley, Torgny N. Fredrickson, Herbert C. Morse III. Expression of the cyclin-dependent kinase inhibitor p27 and its deregulation in mouse B-cell lymphomas. Leukemia Research (30) 153-163, February (2006). (paper)
Tin Lab Lee, Jason Yeh, Carter Van Waes and Zhong Chen. Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas. Mol Cancer Ther 5(1) 8-19, January (2006). (paper)
N Chen, MN Szentirmay, SA Pawar, M Sirito, J Wang, Z Wang, Q Zhai, H-X Yang, DM Peehl, JL Ware and M Sawadogo. Tumor-suppression function of transcription factor USF2 in prostate carcinogenesis. Oncogene 1-9 (2005) (paper)
Ming Li, Sandeep Sood, Su Wang, Mingzhu Fang, Peng Wang, Zheng Sun, Chung S. Yang and Xiaoxin Chen. Overexpression of 5-Lipoxygenase and Cyclooxygenase2 in Hamster and Human Oral Cancer and Chemopreventive Effects of Zileuton and Celecoxib. Clinical Cancer Research Vol. 11, 2089-2096, (2005). (paper)
Min Yan, Ronald M. Rerko, Petra Platzer, Dawn Dawson, Joseph Willis, Min Tong, Earl Lawrence, James Lutterbaugh, Shilong Lu, James K. V. Wilson, Guang bin Luo, Jack Hensold, Hsin Hsiung Tai, Keith Wilson, and Sanford D. Markowitz. 15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGFg induced suppressor of human gastrointestinal cancers. PNAS Vol.101, No. 50, 17468-17473 (2004). (paper)
Luping Wang, JiyaoYuc, Jian Ni, Xue-Ming Xua, Jianjin Wang, Haoyong Ning, Xu-Fang Peia, Jinguo Chen, Shanmin Yang, Charles B. Underhilla, Lei Liu, Joeri Liekensh, Joseph Merregaerth, Lurong Zhang. Extracellular matrix protein1 (ECM1) is over-expressed in malignant epithelial tumors. Cancer Letter Vol. 200 75-67 (2003) (paper)
Holger Moch, Juha Kononen, Olli-P. Kallioniemi, and Guido Sauter, Tissue microarrays: what will they bring to molecular and anatomic pathology. Advances in Anatomic Pathology Vol.8, No.1,14-20, (2001).
Ronald Simon, Jan Richter, Urs Wagner, et al., High-throughput tissue microarray analysis of 3p25 (RAF1) and 8p12 (FGFR1) copy number alterations in urinary bladder cancer. Cancer Res. 61:4514-4519, (2001).
Mark A. Rubin. Use of laser capture microdissection, cDNA microarrays, and tissue microarrays in advancing our understanding of prostate Cancer. J. Pathol. 195:80-86, (2001).
Olli-P. Kallioniemi, Urs Wagner, Juha Kononen and Guido Sauter, Tissue microarray technology for high-throughput molecular profiling of cancer. Human Molecular Genetics Vol.10, No.7, 657-662, (2001).
David L. Rimm, Robert L. Camp, Lori A.Charette, et al., Tissue microarray: a new technology for amplification of tissue resources. The Cancer Journal Vol.7, No.1, (2001).
Lukas Bubendorf, Antonio Nocito, Holger Moch and Guido Sauter, Tissue microarray (TMA) technology: miniaturized pathology archives for high -Throughput in situ studies. J. Pathol. 195:72-79, (2001).
Chad R. Englert, Galina V. Baibakov, and Michael R. Emmert-Buck, Cancer Res. 60:1526-1530, (2000).
F. von Eggeling, H. Davies, L. Lomas, W. Fiedler, K. Junker, U. Claussen and G. Ernst, Tissue-specific microdissection coupled with proteinchip array technologies: applications in cancer research. Biotechniques Vol.29, No.5, 1066-1070, (2000).
Olivier Braissant and Walter Wahli, A simplified in situ hybridization protocol using non-radioactively labeled probes to detect abundant and rare mRNAs on tissue sections. Biochemica No.1, 10-16, (1998). |